Evidence map›Paper›PMID 30154451›Full record

ArticleCell death & disease2018

TGF-β1-SOX9 axis-inducible COL10A1 promotes invasion and metastasis in gastric cancer via epithelial-to-mesenchymal transition.

Tingting Li, Haipeng Huang, Guangyao Shi, Liying Zhao, Tuanjie Li, Ze Zhang, Ruoyan Liu, Yanfeng Hu, Hao Liu, Jiang Yu and 1 more

Open access · goldAbstract read
In one paragraph

Article in Cell death & disease, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 114 papers.

0numbers the graph read from it
0cells of the map it votes in
114citing papers in PubMed
9.2field-weighted citation impact, top 1% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

114 citing papers in PubMed, 182 citations in OpenAlex.

  1. Article
  2. Review
  3. Review
  4. Article
  5. Article
  6. Review
  7. Article
  8. Article
  9. Article
  10. Review
  11. Article
  12. The functional role of the extracellular matrix in inflammatory bowel disease associated gut fibrosis.Matrix biology : journal of the International Society for Matrix Biology · 2025
    Review
  13. Article
  14. Article
  15. Article
  16. Article
  17. Review
  18. Article
  19. Article
  20. Article

54 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors at 3 institutions in 2 countries.

Tingting LiDepartment of General Surgery, Nanfang Hospital, Southern Medical University, Guangzhou, China.ORCID 0000-0001-9209-0602
Haipeng HuangDepartment of General Surgery, Nanfang Hospital, Southern Medical University, Guangzhou, China.
Guangyao ShiDivision of Cardiology, Third Affiliated Hospital, Sun Yat-sen University, Guangzhou, China.
Liying ZhaoDepartment of General Surgery, Nanfang Hospital, Southern Medical University, Guangzhou, China.
Tuanjie LiDepartment of General Surgery, Nanfang Hospital, Southern Medical University, Guangzhou, China.
Ze ZhangDepartments of Maxillofacial and Otorhinolaryngology Oncology; Department of Head and Neck Surgery, Tianjin Medical University Cancer Institute and Hospital; National Clinical Research Center for Cancer, Key Laboratory of Cancer Prevention and Therapy, Tianjin; Tianjin's Clinical Research Center for Cancer, Tianjin, China.
Ruoyan LiuDepartment of Gynecologic Oncology, Tianjin Medical University Cancer Institute and Hospital; National Clinical Research Center for Cancer, Key Laboratory of Cancer Prevention and Therapy, Tianjin, Tianjin's Clinical Research Center for Cancer, Tianjin, China.
Yanfeng HuDepartment of General Surgery, Nanfang Hospital, Southern Medical University, Guangzhou, China.
Hao LiuDepartment of General Surgery, Nanfang Hospital, Southern Medical University, Guangzhou, China. liuhofbi@163.com.
Jiang YuDepartment of General Surgery, Nanfang Hospital, Southern Medical University, Guangzhou, China. balbc@163.com.
Guoxin LiDepartment of General Surgery, Nanfang Hospital, Southern Medical University, Guangzhou, China. gzliguoxin@163.com.
Nanfang Hospital · CNTianjin Medical University Cancer Institute and Hospital · CNSun Yat-sen University · CN

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Molecular biomarkers that predict disease progression might promote drug development and therapeutic strategies in aggressive cancers, such as gastric cancer (GC). High-throughput mRNA sequencing (RNA-seq) revealed that collagen type X alpha 1 (COL10A1) is a disease progression-associated gene. Analysis of 103 GC patients showed that high COL10A1 mRNA expression was associated with GC metastasis and reduced survival. We analyzed the COL10A1 promoter using the UCSC genome website and JASPAR database, and we found potential SOX9 binding site. Here, we demonstrated that SOX9 and COL10A1 were both up-regulated in GC. We observed a positive correlation between the expression patterns of SOX9 and COL10A1 in GC cells and tissues. The results of electrophoretic mobility shift assay (EMSA), chromatin immunoprecipitation (ChIP) assay and promoter reporter indicated that SOX9 could directly bind to the COL10A1 gene promoter and activate its transcription. Biological function experiments showed that COL10A1 regulated the migration and invasion of GC cells. Knockdown COL10A1 inhibited lung and abdominal cavity metastasis in a nude mouse model. Moreover, transforming growth factor-β1 (TGF-β1) treatment up-regulated the phosphorylation of Smad2 and increased SOX9 and COL10A1 expression. COL10A1 was confirmed to be a potential inducer of epithelial-to-mesenchymal transition (EMT). SOX9 was essential for COL10A1-mediated EMT, and cell migration, invasion and metastasis. Co-expression of SOX9 and COL10A1 was associated with tumor progression and was strongly predictive of overall survival in GC patients. In summary, this study elucidated the mechanistic link between COL10A1 and the TGF-β1-SOX9 axis. These findings indicated that COL10A1 might play a crucial role in GC progression and serve as a potential biomarker and therapeutic target in GC patients.

Indexed as

AnimalsCell Line, TumorCell MovementCollagen Type XEpithelial-Mesenchymal TransitionFemaleHumansMaleMiceMice, Inbred BALB CMice, NudeMiddle AgedNeoplasm InvasivenessSignal TransductionSOX9 Transcription FactorStomach NeoplasmsCol10a1 protein, mouseCollagen Type XSOX9 protein, humanSOX9 Transcription FactorTGFB1 protein, humanTransforming Growth Factor beta1

Identifiers

PMID30154451
PMCPMC6113209
OpenAlexW2889069320

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.